P4229Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action

Citation:

Efentakis P, Iliodromitis EK, Varela A, Chavdoula E, Sigala F, Kostomitsopoulos N, Farmakis D, Tasouli A, Papapetropoulos A, Klinakis A, et al. P4229Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action. European Heart Journal. 2017;38.